SEC Filing Summary: Tempur-Pedic International Inc. (10-Q)
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended June 30, 2007. Tempur-Pedic International Inc. is a leading manufacturer and distributor of premium mattresses and pillows sold globally under the TEMPUR and Tempur-Pedic brands. The company operates through two reportable segments: Domestic (U.S. manufacturing and sales) and International (Denmark manufacturing and global distribution outside the U.S.).
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2007 |
Three Months Ended June 30, 2006 |
Six Months Ended June 30, 2007 |
Six Months Ended June 30, 2006 |
|---|---|---|---|---|
| Net Sales | $257,642 | $218,962 | $523,674 | $447,548 |
| Gross Profit | $124,569 | $106,516 | $252,228 | $217,770 |
| Gross Margin | 48.4% | 48.6% | 48.2% | 48.7% |
| Operating Income | $55,130 | $47,225 | $108,884 | $94,290 |
| Net Income | $32,931 | $26,112 | $62,711 | $53,005 |
| Diluted EPS | $0.39 | $0.30 | $0.74 | $0.59 |
| Cash from Operations (6mo) | $74,184 | $86,510 | ||
| Free Cash Flow (6mo) | ||||
| Total Debt (Long-term + Current) | $401,631 (as of June 30, 2007) | |||
| Cash and Equivalents | $24,832 (as of June 30, 2007) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18% year-over-year for the quarter and 17% for the six-month period. Growth was driven primarily by the Retail channel (up 22% QoQ) and mattress sales (up 20% QoQ).
- Profitability: Net income rose 26% for the quarter and 18% for the six-month period. Diluted EPS increased 30% to $0.39.
- Margin Pressure: Gross margins declined slightly (48.4% vs 48.6% in Q2) due to incremental depreciation and startup costs associated with the new Albuquerque, New Mexico manufacturing facility. Management expects a full-year negative impact of up to 1% on gross margins.
- Expense Increases: Selling and marketing expenses rose 17% due to a new U.S. media campaign. General and administrative expenses increased 15%, partly due to stock-based compensation and bad debt charges related to a U.S. customer reorganizing under Chapter 11.
- Debt and Liquidity: Long-term debt increased to $401.6 million from $341.6 million at year-end 2006. This increase funded share repurchases ($100 million) and dividends. Operating cash flow decreased to $74.2 million (6mo) from $86.5 million, primarily due to a $14.5 million cash outflow for increased inventory levels.
Guidance, Outlook, and Risks
- Capital Allocation: The company initiated a cash dividend program in 2007 ($0.08 per share quarterly) and completed a $100 million share repurchase authorization in Q2. A new $200 million repurchase authorization was approved in July 2007.
- Capital Expenditures: Expected to be approximately $15 million for 2007, a decrease from prior years as the Albuquerque facility construction is complete.
- Legal Proceedings: The company is defending against a securities class action lawsuit regarding 2005 disclosures, derivative suits against officers/directors, and an antitrust class action regarding mattress pricing. Management believes these claims lack merit but notes the inherent uncertainty of litigation.
- Risk Factors: Key risks include high financial leverage (debt-to-equity ratio), dependence on top five customers (17% of sales), foreign currency exchange rate fluctuations, and production concentration in only three global facilities.
Investor Verification Checklist
- Inventory Build: Verify the necessity of the $14.5 million increase in inventory levels and its impact on future working capital requirements.
- Debt Covenants: Confirm continued compliance with financial covenants (leverage and interest coverage ratios) given the increased debt load from share buybacks.
- Legal Exposure: Monitor the status of the securities class action and antitrust litigation for potential material adverse effects.
- Margin Recovery: Track the ramp-up of the Albuquerque facility to ensure startup costs and depreciation do not permanently erode gross margins.
- Customer Concentration: Assess the stability of the top five customers, which represent 17% of total sales.